Performance of the F-PSMA 1007 PET/CT for high-risk prostate cancer staging: Experience from a Latin American reference center.

Authors

null

Sebastian Peña Rodriguez

Fundación Santa Fe de Bogotá, Bogotá, Colombia

Sebastian Peña Rodriguez , Cesar Alejandro Diaz Ritter , Juan Ignacio Caicedo , Natalia Ramirez , Julian Rojas , Andres Felipe Gutierrez , Maria Paula Mogollón , Camilo Medina

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Diagnostics and Imaging

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 286)

DOI

10.1200/JCO.2024.42.4_suppl.286

Abstract #

286

Poster Bd #

L21

Abstract Disclosures

Similar Posters

First Author: Bridget F. Koontz

Poster

2022 ASCO Genitourinary Cancers Symposium

68 Ga-PSMA PET/CT for preoperative lymph nosde staging of high-risk prostate cancer.

68 Ga-PSMA PET/CT for preoperative lymph nosde staging of high-risk prostate cancer.

First Author: Axel Heidenreich

First Author: Ashanda Rosetta Patrice Esdaille

Poster

2024 ASCO Genitourinary Cancers Symposium

PSMA PET imaging for evaluation of recurrent or persistent prostate cancer after primary prostate radiation.

PSMA PET imaging for evaluation of recurrent or persistent prostate cancer after primary prostate radiation.

First Author: Richard Bennett IV